Use for long periods or in high doses near the expected delivery date is not recommended because of possible harm to the unborn baby.

Neonatal-care providers should be informed of maternal sulfa or dapsone therapy if used near the delivery date because of the theoretical increased risk for hyperbilirubinemia and kernicterus (178).

This medication should not be used near the expected delivery date because of possible harm to the unborn baby.

Caution is advised if this medication is used near the expected delivery date because similar drugs may cause harm to a newborn.